|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
2015 NSH Laboratory Webinar Series
Laboratory Webinars are a great, inexpensive way to provide continuing education to a large number of employees. The cost for each session is the same regardless of the number of attendees. The one-hour session is held the fourth Wednesday of the month, beginning at 1 p.m. EDT. Online registration is now open! Register by Jan. 28, 2015 to receive the full series for only $1,350. View the complete schedule of webinars here.
Breakthrough Replicates Human Brain Cells for Use in Alzheimerâs Research
The New York Times
For the first time, and to the astonishment of many of their colleagues, researchers created what they call Alzheimer's in a Dish — a petri dish with human brain cells that develop the telltale structures of Alzheimer's disease. In doing so, they resolved a longstanding problem of how to study Alzheimer's and search for drugs to treat it; the best they had until now were mice that developed an imperfect form of the disease.
Datacolor CHROMACAL standardizes color in digital brightfield images.
• Save time; no need for Photoshop!
• Accelerated workflow and batch processing.
• Reliable, consistent, standardized color and brightness.
• Get the best image the first time, all the time.
• FREE SLIDE OFFER. Click here
ChromaCal…Empowering Science with Color Integrity
Companies developing non-invasive and wearable glucose monitoring devices that can report test data in real time to physicians and clinical labs
Because of the tremendous volume of glucose tests performed daily throughout the world, many companies are developing non-invasive methods for glucose testing. Their goal is a patient-friendly technology that does not require a needle stick or venipuncture and may even eliminate the need to send specimens to a medical laboratory.
Russian HIV vaccine ready for phase 2 clinical trials
The Moscow Times
Russian researchers in Novosibirsk announced recently that they are ready to proceed with the second phase of clinical trials for an HIV/AIDS vaccine, but need $4.9-7.3 million to fund the trials, RIA Novosti reported, citing a top scientist involved in the project.
A U.S. attempt to cure a baby born with HIV was originally reported to be successful when announced in March, but several months later tests showed that the virus had returned.
New $1 Million NIH grant enables clinical trials of artificial pancreas for individuals with Type 1 diabetes
Rensselaer Polytechnic Institute
A multi-university research team led by Rensselaer Polytechnic Institute has received a $1 million grant from the U.S. National Institutes of Health to conduct clinical trials of their closed-loop artificial pancreas for individuals with Type 1 diabetes.
The three-year study, funded by the NIH National Institute of Diabetes and Digestive and Kidney Diseases, will test the artificial pancreas system in a group of patients with Type 1 diabetes. The study will begin with 12 patients using the system in a hospital setting, and progress to a group of 18 patients using the system at home for two weeks.
Ebola and the epidemics of the past
The Wall Street Journal
Just a few generations ago, progress against infectious disease convinced Americans that modern medicine had won the battle against microbes. Why is the public so skeptical today?
Chronic kidney disease associated with increased risk of renal and urothelial cancers
Does renal disease increase one’s risk of developing cancer? We know there is a well-studied association between end-stage renal disease and cancer risk, but whether or not less severe forms of kidney disease place patients at an increased risk for various cancers is uncertain. A recent study from Huntsman Cancer Institute at the University of Utah, Kaiser Permanente Division of Research, and Memorial Sloan Kettering Cancer Center has shed some new light on this question.
GBI Labs produces the largest selection of secondary detection kits, from single to multiple detection kits, with wide range host species.
We provide FREE samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market with 20%-30% cost less.
Stem-cell replication to treat blood diseases
Human clinical trials are set to start in December to test an innovative approach to treating life-threatening blood diseases, such as leukemia.
A team of researchers from the Institute for Research in Immunology and Cancer of the University of Montréal have discovered a new molecule, UM171, that can be used to increase the number of stem cells found in umbilical cord blood. The innovative finding, which has been described as a world breakthrough, was published Sept. 19, 2014 in Science.
Perspective on: A microanalysis lab
A Lab of Leaders
Each day involves something new at the McCrone Associates microanalysis lab. Dealing with a huge range of industries means lab staff do non-routine investigative microanalyses of a variety of samples and often have to create new methods altogether to complete the work a customer needs. Sometimes that makes for a big challenge, but it’s also what makes working at McCrone Associates so interesting and is one of the main reasons staff tend to stick around.
Clearing up clinical trials: Myths and misconceptions
Memorial Sloan Kettering Cancer Center
In a recent blog post about clinical trials, medical oncologist Paul Sabbatini shed light on how phase I trials are conducted at Memorial Sloan Kettering and how to know if you should consider participating in one. In this Q&A, Dr. Sabbatini demystified common myths and misconceptions surrounding clinical trials.
New test to diagnose thyroid cancer
Thyroid cancer is the most rapidly increasing type of cancer in the U.S, with 63,000 new cases diagnosed in the past year. Traditionally, doctors diagnose thyroid cancer with a fine needle biopsy — a painful procedure that is only accurate fifty percent of the time — meaning additional surgery for some patients. As Martie salt shows us, researchers have developed a new test that improves diagnosis — the first time around.
Missed last week's issue? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063